

Dexcom Advances Pediatric Diabetes Care with Stelo's OTC FDA Approval for Continuous Glucose Monitoring
Charles River Laboratories Upgraded to Overweight by Morgan Stanley Amid Competitive Sector Scrutiny
Conmed Appoints John E. Gallagher as CFO, Aiming for Growth in Minimally Invasive Surgery
Bruker Enhances Diagnostic Capabilities and Expands Financing Strategies in Healthcare Sector
Brookdale Senior Living Boosts Occupancy and Strengthens Strategy with New Sales Chief Appointment
Centene Corporation Launches Voluntary Separation Program Amid Membership Decline and Operational Challenges
Celldex Therapeutics Shows Promising Phase 2 Results for Chronic Spontaneous Urticaria Treatment
BioCryst Pharmaceuticals Advances HAE Treatments with Promising Clinical Data at EAACI 2026
BioMarin Advances Pediatric Growth Treatment with Promising Data on VOXZOGO and BMN 333
Molina Healthcare Wins Illinois Medicaid Contract and Reports Improved Q1 2026 Margins
McKesson Strengthens Financial Position with $2.25 Billion Loan Amid Market Challenges
Ligand Pharmaceuticals Board Actions Signal Confidence in Future Growth and Innovation
Gilead Sciences Donates Remdesivir to Combat Ebola, Reinforcing Global Health Commitment
Bristol Myers Squibb Advances Multiple Myeloma Treatments with Promising Clinical Trial Results
Intuitive Surgical Faces Regulatory Challenges and Recalls Amid Transition to New Technologies
Eli Lilly's Innovations in Oncology and Pain Management Drive Healthcare Advancements and Investor Confidence
Johnson & Johnson's TALVEY Shows Promise in Multiple Myeloma Treatment and Expands Oncology Focus
Edwards Lifesciences Positioned for Growth Following Changes in TAVR Coverage Policies
UnitedHealth Group Positions for Growth Amidst Surge in Healthcare Employment Trends
Baxter International Focuses on Core Medtech After Kidney Care Divestiture for Growth.
Agilent Technologies Expands Diagnostics and Integrates AI to Enhance Cancer Treatment Solutions
Perrigo's Leadership Shakeup: New Interim CEO Appointed Amid CEO Resignation Concerns
AbbVie’s Allergan Aesthetics Gains FDA Approval for Innovative SKINVIVE Neck Treatment
Biogen Acquires RayThera for $1 Billion to Enhance Neurological Treatment Portfolio.
Castle Biosciences Achieves Over 100,000 Clinical Test Orders for TissueCypher® Barrett's Esophagus Test
MetaVia Advances Cardiometabolic Disease Treatments with Promising Drug Candidates and Upcoming Investor Forum
Outlook Therapeutics Advances ONS-5010 Approval, Paving the Way for Market Entry
Wave Life Sciences Advances RNA Editing with Promising WVE-006 for Genetic Disorders
Ionis Pharmaceuticals Shares Promising Oleazarsen Data to Navigate Competitive Lipid Management Market
Axsome Therapeutics Achieves Patent Settlement for SUNOSI, Securing Market Stability Until 2040
AMN Healthcare Services Strengthens Leadership Team to Drive Growth and Innovation
NovoCure Appoints Frank Leonard to Board Amid Strategic Shift in Governance and Market Challenges
Penumbra’s THUNDERBOLT Technology Gains CE Mark Certification for Stroke Management Advancement
uniQure Advances Huntington's Disease Gene Therapy Following Positive FDA Meeting and Upcoming BLA Submission
Viking Therapeutics Appoints Dr. Hubert C. Chen as Chief Medical Officer for Drug Approval Strategy